Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Update Il y a 4 ans
Reference: NCT00122486

Woman Man

Extract

This Phase 2 study involving tenofovir disoproxil fumarate (TDF) will assess the extended safety of TDF 300 mg per day among young women who are not HIV-infected.


Inclusion criteria

  • HIV Infections

Links